How to Manage and Treat a Psoriatic Arthritis (PsA)
Patient Population to Improve Outcomes
Post Test

A score of 70% must be achieved to receive continuing education credits.
 
1. Psoriatic Arthritis is a disabling condition and patients with PsA may have significant morbidity, disability and early mortality.
 True
 False
2. Psoriatic Arthritis clinical symptoms include:
 a. Joint inflammation of the small joints of the fingers
 b. Dactylitis
 c. Nail changes
 d. All the above
3. A feature of PsA distinct from Rheumatoid Arthritis is where tendons, ligaments or joint capsule fiber inserts in bone.
 True
 False
4. What percent of patients with Psoriasis have Psoriatic Arthritis?
 a. 20
 b. 30
 c. 50
 d. 75
5. Moll and Wright criteria on PsA was developed in the________________________.
a. Late 1960s
 b. Early 1970s
 c. Mid 1970s
 d. Late 1970s
6. The CASPAR Study diagnostic criteria for PsA in any patient would include inflammatory arthritis, spine disease, or etheseal and 3 or more of the following: Psoriasis, nail changes, a negative test for RF, Dactylitis, or radiological evidence of juxta-articular new bone formation.
   True
   False
7. Radiologic features of Psoriatic Arthritis include “pencil in cup” joint erosion and Sacroilitis.
   True
   False
8. Traditional systemic DMARDs are indicated for more active disease signs and symptoms, but have not been proven to retard disease progression or effectively treat the spine.
  True
   False
9. What are the PsA and anti-TNFs co-morbidities?
 a. Cardiovascular Disease
 b. Osteoporosis
 c. Infections
 d. Lymphoma
 e. Depression
 f. All the above
10. Biologic, particularly anti-TNF, agents have not been proven effective for the PsA treatment of peripheral arthritis, skin and nail disease, Dactylitis, Enthesitis and Axial Disease.
   True
   False

 

Activity Evaluation

Please rate this activity on the following scale:
4 - Excellent        3 - Good        2 - Fair        1 - Poor
1.Based on the content presented I am better able to:  
  • Describe the role of inflammation in psoriatic arthritis
    4        3        2        1
  • Evaluate current treatment options for psoriatic arthritis
    4        3        2        1
  • Discuss the impact psoriatic arthritis has on the patient's overall health status
    4        3        2        1
2. Activity met my expectations    4        3        2        1  
3. Activity was free of bias    4        3        2        1
4. Activity content was understandable    4        3        2        1
5. Presenter was free of bias    4        3        2        1
6. Method of learning was beneficial    4        3        2        1


Due to the content of this activity, I will change my practice patterns by:

Providing appropriate education to patients
Work with our rheumatologist and primary care providers to establish an appropriate treatment choice
Be aware of the challenges of managing psoriatic arthritis
My practice patterns will not change
Other    Specify:

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 6 months from your post test submission to monitor change.
Name:  
Profession: MD  DO  RN  LPN  Other
Company:  
Mailing Address:  
City, State, Zip:  
Phone:  
Fax:  
Email:  
Heard About Activity By: eNews  Colleague  Internet    JMCM Article
 Email   Phone
 
Send my certificate by: U.S. Mail             Email